HUL finishes securing of hygiene brand VWash from Glenmark Pharma Kumar Jeetendra | June 26, 2020 Hindustan Unilever Limited (HUL) on Friday reported that it has finished the securing of cozy cleanliness brand VWash from Glenmark Pharmaceuticals Ltd. In an administrative recording, HUL said that it has obtained the protected innovation rights including trademarks, structure, and expertise identified with the VWash brand around the world. The securing was reported on March …
Glenmark Pharma gets USFDA gesture to showcase drug for backsliding numerous sclerosis Kumar Jeetendra | October 7, 2020 Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for treatment of relapsing forms of multiple sclerosis in adults. Quoting IQVIA sales data for the 12 month period ending August 2020, Glenmark said Tecfidera delayed-release capsules, 120 mg and 240 mg, …
Glenmark Pharma gets provisional gesture from USFDA for blood thinning drug Kumar Jeetendra | December 21, 2020 Pradaxa is used to prevent blood clots from forming due to certain irregular heart rhythm. Glenmark Pharmaceuticals was granted tentative approval by the United States Food and Drug Administration (USFDA) for Dabigatran Etexilate capsules at the advantages of 75 mg, 110 mg, and 150 mg, the company said in a regulatory filing. Quoting IQVIA sales …
Glenmark Pharmaceuticals gets USFDA gesture for conventional antipsychotic drug Kumar Jeetendra | March 24, 2021 Drug firm Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator because of its generic phenothiazine antipsychotic Chlorpromazine Hydrochloride tablets. “The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, …
Glenmark Pharma gets USFDA gesture for Icatibant Injection Kumar Jeetendra | May 25, 2021 Drug major Glenmark Pharma on Monday said it has received final approval from the US health regulator for Icatibant Injection, indicated for the treatment of acute attacks of hereditary angioedema (HAE). Hereditary angioedema (HAE) is a disorder that results in recurrent attacks of severe swelling. The approved product is a generic version of Firazyr Injection …
Glenmark Pharma gets conditional USFDA nod for generic Regadenoson injection Kumar Jeetendra | January 21, 2022 Glenmark Pharmaceuticals on Monday said its US arm has received tentative approval from the country’s health regulator for its generic Regadenoson injection. Regadenoson injection is given during the preparation for a radiologic examination of blood flow through the heart to test for coronary artery disease. According to a statement, the tentative approval was granted by …
